This is a continuation application for a project examining the influence of other drug use on human cocaine use using a laboratory model. The prior project focused on the influence of non-prescription drug use (i.e., alcohol, caffeine, marijuana, and nicotine) and the proposed project will focus on the influence of prescription drug use (i.e., psychomotor stimulants, sedative hypnotics, and opioid analgesics). Understanding the influence of such other drug use on the probability of cocaine use is essential to the development of effective clinical strategies for managing polydrug abuse in cocaine treatment clinics, and could also prove useful to the development of effective pharmacotherapies for cocaine abuse. Laboratory models are important due to the rigorous experimental control they afford and their lower costs compared to clinical trials. In our laboratory model, volunteers participate in a series of experimental sessions in which they make exclusive choices between doses of intranasal cocaine and varying amounts of money. In studies completed to date (l) cocaine use varied as an orderly function of monetary value, demonstrating experimental control over drug use; (2) acute alcohol, but not caffeine, pretreatment increased preference for cocaine over the alternative monetary option, suggesting the model has pharmacological sensitivity and selectivity; and (3) these laboratory findings were concordant with evidence from clinic studies with cocaine-dependent patients, supporting the generalizability of these observations to treatment settings. Six studies are proposed for the next funding period. All examine the acute effects of prescription drugs that are commonly used and abused by cocaine abusers. The specific drugs proposed for study are damphetamine, methylphenidate, pentobarbital, triazolam, codeine, and buprenorphine. These studies wTh provide important new information on (l) how use of these drugs alters preference for cocaine versus alternative, non-drug reinforcers, (2) possible differences between drugs in how they affect cocaine use, and (3) the utility of laboratory models for addressing clinically important issues. Additionally, by examining non-prescription (prior application) and prescription (this application) drugs, this project will contribute a comprehensive experimental analysis of the influence of commonly used drugs on human cocaine use.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA008076-09
Application #
6378556
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Hoffman, Allison
Project Start
1993-02-01
Project End
2002-06-30
Budget Start
2001-09-01
Budget End
2002-06-30
Support Year
9
Fiscal Year
2001
Total Cost
$231,323
Indirect Cost
Name
University of Vermont & St Agric College
Department
Psychiatry
Type
Schools of Medicine
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Streck, Joanna M; Heil, Sarah H; Higgins, Stephen T et al. (2018) Tobacco withdrawal among opioid-dependent smokers. Exp Clin Psychopharmacol 26:119-124
Bradstreet, Matthew P; Higgins, Stephen T; McClernon, F Joseph et al. (2014) Examining the effects of initial smoking abstinence on response to smoking-related stimuli and response inhibition in a human laboratory model. Psychopharmacology (Berl) 231:2145-58
Chivers, Laura L; Higgins, Stephen T (2012) Some observations from behavioral economics for consideration in promoting money management among those with substance use disorders. Am J Drug Alcohol Abuse 38:8-19
Comer, Sandra D; Bickel, Warren K; Yi, Richard et al. (2010) Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society. Behav Pharmacol 21:251-77
Chivers, Laura L; Higgins, Stephen T; Heil, Sarah H et al. (2008) Effects of initial abstinence and programmed lapses on the relative reinforcing effects of cigarette smoking. J Appl Behav Anal 41:481-97
Silverman, Kenneth; Roll, John M; Higgins, Stephen T (2008) Introduction to the special issue on the behavior analysis and treatment of drug addiction. J Appl Behav Anal 41:471-80
Yoon, Jin H; Higgins, Stephen T (2008) Turning k on its head: comments on use of an ED50 in delay discounting research. Drug Alcohol Depend 95:169-72
Sigmon, Stacey C (2007) Investigating the pharmacological and nonpharmacological factors that modulate drug reinforcement. Exp Clin Psychopharmacol 15:1-20
Sigmon, Stacey C; Higgins, Stephen T (2006) Voucher-based contingent reinforcement of marijuana abstinence among individuals with serious mental illness. J Subst Abuse Treat 30:291-5
Lussier, Jennifer Plebani; Heil, Sarah H; Mongeon, Joan A et al. (2006) A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 101:192-203

Showing the most recent 10 out of 46 publications